Gene Therapy Latest News | Experimental Gene Therapy Studies

Roctavian, Hem A Gene Therapy, Sustains Drop in Bleeding Rates, Phase 3 Data Show

13 January 2021

Non-viral Gene Therapy Shows Promise in Hemophilia A Animal Models

06 January 2021

BioMarin Announces Positive Phase 3 Gene Therapy Trial Results in Adults with Severe Hemophilia A; Study Met All Primary and Secondary Efficacy Endpoints in One-Year Data Set

10 January 2021

Freeline Reports Updated Data From Phase 1/2 B-AMAZE Trial in Hemophilia B

14 December 2020

UniQure Shares Long-term Data About AMT-061 and AMT-060 Gene Therapy Candidates
09 December 2020
Gene Therapy AMT-060 for Hemophilia B Prevents Bleeds Up to 5 Years, Ongoing Trial Shows
03 December 2020
Gene therapy to cure haemophilia: Is robust scientific inquiry the missing factor?
01 December 2020
Most Hemophilia Patients Show Positive Attitude for Gene Therapy in Study
30 November 2020

I agree with the Terms and conditions and the Privacy policy

About

Supported by educational grants from BioMarin, Freeline Therapeutics Limited, Pfizer Inc., Shire, Spark Therapeutics, and uniQure, Inc

Essential SSL